RSRosario Scaglione

Rosario Scaglione

*This is an algorithmically generated author record based on publicly available information.

Rosario Scaglione has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandro Del Cuore

    Cardiology Unit, Cervello Hospital, A.O. Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy

    1 shared publication
  • Antonino Tuttolomondo

    A Dipartimento PROMISE , University of Palermo, School of Medicine , Palermo , ltaly

    1 shared publication
  • Antonino Tuttolomondo

    Internal Medicine and Stroke Care Ward, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialities, University of Palermo, 90127 Palermo, Italy

    1 shared publication
  • Antonio Pinto

    A Dipartimento PROMISE , University of Palermo, School of Medicine , Palermo , ltaly

    1 shared publication
  • Antonio Pinto

    Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, 80131 Naples, Italy

    1 shared publication
  • Daniela Colomba

    A Dipartimento PROMISE , University of Palermo, School of Medicine , Palermo , ltaly

    1 shared publication

Latest Publications

  • Open Access

    Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators

    by Tiziana Di Chiara, Alessandro Del Cuore, Mario Daidone, Stefania Scaglione, Rosario Luca Norrito, Maria Grazia Puleo, Rosario Scaglione, Antonio Pinto, Antonino Tuttolomondo

    There is growing evidence that hypertension is the most important vascular risk factor for the development and progression of cardiovascular and cerebrovascular diseases. The brain is an early target of hypertension-induced organ damage and may manifest as stroke, subclinical cerebrovascular abnormalities and cognitive decline. The pathophysiological mechanisms of these harmful effects remain to be completely clarified. Hypertension is well known to alter the structure and function of cerebral blood vessels not only through its haemodynamics effects but also for its relationships with endothelial dysfunction, oxidative stress and inflammation. In the last several years, new possible mechanisms have been suggested to recognize the molecular basis of these pathological events. Accordingly, this review summarizes the factors involved in hypertension-induced brain complications, such as haemodynamic factors, endothelial dysfunction and oxidative stress, inflammation and intervention of innate immune system, with particular regard to the role of Toll-like receptors that have to be considered dominant components of the innate immune system. The complete definition of their prognostic role in the development and progression of hypertensive brain damage will be of great help in the identification of new markers of vascular damage and the implementation of innovative targeted therapeutic strategies.


  • Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities

    by Tiziana Di Chiara, Antonino Tuttolomondo, Gaspare Parrinello, Daniela Colomba, Antonio Pinto, Rosario Scaglione

    Background: It has been reported that changes in cardiac structure and ventricular function associated with obesity have to be attributable to hemodynamic and non-hemodynamic alterations. Accordingly, the aim of this was to evaluate left ventricular hypertrophy (LVH) prevalence and its effect on left ventricular systolic and diastolic function in a cohort of obese patients. Materials and Methods: LV internal diameter (LVID), left ventricular mass (LVM) and LVM/height2.7(LVMI), relative wall thickness (RWT), LV ejection fraction (LVEF), E/A ratio, isovolumic relaxation time, deceleration time of E velocity by echocardiography and pulsed-wave Doppler and total circulating adiponectin (ADPN) by radioimmunoassay were measured in 319 obese subjects with and without LVH. Results: Increased values of BMI, WHR, SBP, DBP, MBP LVID, LVM, LVMI, IVST (p < .001), increased prevalence of subjects with LVEF< 50%,(p < .001), central fat distribution (p < .001), hypertension (p < .001), diabetes (p < .001), metabolic syndrome (p < .02), and reduced value of ADPN (p < .0001) and LVEF (p < .001) were detected in LVH obese subjects than controls without LVH. No significant differences in diastolic parameters were observed between the two groups. LVEF correlated directly with ADPN (p < .0001) and inversely with age (p < .01), BMI (p < .01), WHR (p < .001), MBP (p < .01) MetS (p < .02) and LVMI (p < .001). WHR, MBP, LVMI and ADPN were independently associated with LVEF. Conclusions: In conclusion, our data indicate that obese subjects with LVH might be considered a distinct phenotype of obesity, characterised by LVH, increased prevalence of cardiometabolic comorbidities, central fat distribution, hypoadiponectinemia and early left ventricular systolic dysfunction.